Diaceutics Reports Widened Pretax Loss for H1 2023
Diaceutics, a diagnostics company based in the U.K., has announced a widened pretax loss for the first half of 2023. Despite experiencing higher costs, the company remains optimistic about meeting…
Diaceutics, a diagnostics company based in the U.K., has announced a widened pretax loss for the first half of 2023. Despite experiencing higher costs, the company remains optimistic about meeting…